Literature DB >> 12907484

Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study.

I A F van der Mei1, A-L Ponsonby, T Dwyer, L Blizzard, R Simmons, B V Taylor, H Butzkueven, T Kilpatrick.   

Abstract

OBJECTIVE: To examine whether past high sun exposure is associated with a reduced risk of multiple sclerosis.
DESIGN: Population based case-control study.
SETTING: Tasmania, latitudes 41-3 degrees S. PARTICIPANTS: 136 cases with multiple sclerosis and 272 controls randomly drawn from the community and matched on sex and year of birth. MAIN OUTCOME MEASURE: Multiple sclerosis defined by both clinical and magnetic resonance imaging criteria.
RESULTS: Higher sun exposure when aged 6-15 years (average 2-3 hours or more a day in summer during weekends and holidays) was associated with a decreased risk of multiple sclerosis (adjusted odds ratio 0.31, 95% confidence interval 0.16 to 0.59). Higher exposure in winter seemed more important than higher exposure in summer. Greater actinic damage was also independently associated with a decreased risk of multiple sclerosis (0.32, 0.11 to 0.88 for grades 4-6 disease). A dose-response relation was observed between multiple sclerosis and decreasing sun exposure when aged 6-15 years and with actinic damage.
CONCLUSION: Higher sun exposure during childhood and early adolescence is associated with a reduced risk of multiple sclerosis. Insufficient ultraviolet radiation may therefore influence the development of multiple sclerosis.

Entities:  

Mesh:

Year:  2003        PMID: 12907484      PMCID: PMC169645          DOI: 10.1136/bmj.327.7410.316

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  36 in total

1.  The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia.

Authors:  S R Hammond; D R English; J G McLeod
Journal:  Brain       Date:  2000-05       Impact factor: 13.501

2.  The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist?

Authors:  R B Forbes; S V Wilson; R J Swingler
Journal:  J Neurol       Date:  1999-11       Impact factor: 4.849

3.  Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables.

Authors:  E D ACHESON; C A BACHRACH; F M WRIGHT
Journal:  Acta Psychiatr Scand Suppl       Date:  1960

4.  The use of spectrophotometry to estimate melanin density in Caucasians.

Authors:  T Dwyer; H K Muller; L Blizzard; R Ashbolt; G Phillips
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-03       Impact factor: 4.254

5.  MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.

Authors:  D W Paty; J J Oger; L F Kastrukoff; S A Hashimoto; J P Hooge; A A Eisen; K A Eisen; S J Purves; M D Low; V Brandejs
Journal:  Neurology       Date:  1988-02       Impact factor: 9.910

6.  The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart.

Authors:  S R Hammond; J G McLeod; K S Millingen; E G Stewart-Wynne; D English; J T Holland; M G McCall
Journal:  Brain       Date:  1988-02       Impact factor: 13.501

7.  1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4.

Authors:  M T Cantorna; W D Woodward; C E Hayes; H F DeLuca
Journal:  J Immunol       Date:  1998-06-01       Impact factor: 5.422

8.  Vitamin D levels in prepubertal children in Southern Tasmania: prevalence and determinants.

Authors:  G Jones; C Blizzard; M D Riley; V Parameswaran; T M Greenaway; T Dwyer
Journal:  Eur J Clin Nutr       Date:  1999-10       Impact factor: 4.016

9.  Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.

Authors:  P Goldberg; M C Fleming; E H Picard
Journal:  Med Hypotheses       Date:  1986-10       Impact factor: 1.538

10.  Reproducibility of reported measurements of sun exposure in a case-control study.

Authors:  D R English; B K Armstrong; A Kricker
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-10       Impact factor: 4.254

View more
  107 in total

Review 1.  Multiple sclerosis, vitamin D, and HLA-DRB1*15.

Authors:  Lahiru Handunnetthi; Sreeram V Ramagopalan; George C Ebers
Journal:  Neurology       Date:  2010-06-08       Impact factor: 9.910

2.  Migration and multiple sclerosis in United Kingdom and Ireland immigrants to Australia: a reassessment. II. Characteristics of early (pre-1947) compared to later migrants.

Authors:  J G McLeod; S R Hammond; J F Kurtzke
Journal:  J Neurol       Date:  2011-09-23       Impact factor: 4.849

Review 3.  Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop.

Authors:  Frederick W Miller; Lars Alfredsson; Karen H Costenbader; Diane L Kamen; Lorene M Nelson; Jill M Norris; Anneclaire J De Roos
Journal:  J Autoimmun       Date:  2012-06-25       Impact factor: 7.094

4.  Latitude has more significant impact on prevalence of multiple sclerosis than ultraviolet level or sunshine duration in Japanese population.

Authors:  Masako Kinoshita; Kaoru Obata; Masami Tanaka
Journal:  Neurol Sci       Date:  2015-03-10       Impact factor: 3.307

5.  Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle.

Authors:  M T Kampman; T Wilsgaard; S I Mellgren
Journal:  J Neurol       Date:  2007-03-21       Impact factor: 4.849

Review 6.  Solvent neurotoxicity.

Authors:  F D Dick
Journal:  Occup Environ Med       Date:  2006-03       Impact factor: 4.402

7.  Migration and multiple sclerosis in Alaskan military veterans.

Authors:  Mitchell T Wallin; William F Page; John F Kurtzke
Journal:  J Neurol       Date:  2009-04-18       Impact factor: 4.849

8.  Time of birth, residential solar radiation and age at onset of multiple sclerosis.

Authors:  Tzu-Yun McDowell; Sania Amr; Patricia Langenberg; Walter Royal; Christopher Bever; William J Culpepper; Douglas D Bradham
Journal:  Neuroepidemiology       Date:  2010-03-18       Impact factor: 3.282

Review 9.  Therapies for multiple sclerosis: considerations in the pediatric patient.

Authors:  Brenda Banwell; Amit Bar-Or; Gavin Giovannoni; Russell C Dale; Marc Tardieu
Journal:  Nat Rev Neurol       Date:  2011-01-11       Impact factor: 42.937

10.  The causal cascade to multiple sclerosis: a model for MS pathogenesis.

Authors:  Douglas S Goodin
Journal:  PLoS One       Date:  2009-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.